Immune microenvironment of gliomas
Open accessThe DOI matches its Crossref record; 235 of the 235 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–235 of 235
Curran, C. S., Evans, M. D., & Bertics, P. J. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1001965 · Cited by 63
Yan, W., Qian, C., Zhao, P., Zhang, J., Shi, L., Qian, J., Liu, N., Fu, Z., Kang, C., Pu, P., et al. (2010) · Neuro-Oncology · doi:10.1093/neuonc/noq006 · Cited by 61
Kyrkanides, S., Miller, A. W., Miller, J.-N. H., Tallents, R. H., Brouxhon, S. M., Olschowka, M. E., O'Banion, M. K., & Olschowka, J. A. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.06.024 · Cited by 60
Cannabinoid Signaling in Glioma Cells
Ellert‐Miklaszewska, A., Ciechomska, I. A., & Kaminska, B. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-94-007-4719-7_11 · Cited by 59
Self-citationEsiri, M. M., & Morris, C. S. (1991) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(91)90018-3 · Cited by 56
GDNF: a cytokine at the interface of TGF-βs and neurotrophins
Unsicker, K. (1996) · Cell and Tissue Research · doi:10.1007/s004410050686 · Cited by 56
Nishimichi, N., Higashikawa, F., Kinoh, H. H., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m901515200 · Cited by 54
Relevance of Periostin Splice Variants in Renal Cell Carcinoma
Morra, L., Rechsteiner, M., Casagrande, S., Luu, V. D., Santimaria, R., Diener, P. A., Sulser, T., Kristiansen, G., Schraml, P., Moch, H., et al. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.05.035 · Cited by 53
Glial Progenitors as Targets for Transformation in Glioma
Ilkhanizadeh, S., Lau, J., Huang, M., Foster, D. J., Wong, R. A., Frantz, A., Wang, S., Weiss, W. A., & Persson, A. I. (2014) · Advances in cancer research · doi:10.1016/b978-0-12-800249-0.00001-9 · Cited by 52
Prat, E., Baron, P., Meda, L., Scarpini, E. A., Galimberti, D., Ardolino, G., Catania, A., & Scarlato, G. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)00966-6 · Cited by 52
Immune genes are associated with human glioblastoma pathology and patient survival
Vauléon, É., Avril, T., Hamlat, A., Etcheverry, A., Chiforeanu, D. C., Meneï, P., Mosser, J., Quillien, V., & Aubry, M. (2012) · BMC Medical Genomics · doi:10.1186/1755-8794-5-41 · Cited by 51
Moretto, G., Walker, D. G., Lanteri, P., Taioli, F., Zaffagnini, S., Xu, R., & Rizzuto, N. (1996) · Cell and Tissue Research · doi:10.1007/s004410050695 · Cited by 44
Osteopontin regulates development and function of invariant natural killer T cells
Diao, H., Iwabuchi, K., Li, L., Onoé, K., Kaer, L. V., Kon, S., Saito, Y., Morimoto, J. O., Denhardt, D. T., Rittling, S. R., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806089105 · Cited by 44
Gabrusiewicz, K. R., Hossain, M. B., Cortes‐Santiago, N., Fan, X., Kaminska, B., Marini, F. C., Fueyo-Margareto, J., & Gomez‐Manzano, C. (2015) · Neoplasia · doi:10.1016/j.neo.2015.03.003 · Cited by 43
Self-citationMerkel, C. A., Soares, R. B. D. S., de Carvalho, A. C. V., Zanatta, D. B., Bajgelman, M. C., Fratini, P., Costanzi-Strauss, E., & Strauss, B. E. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-316 · Cited by 43
Ultrastructural localization of cellular prion protein (PrPc) at the neuromuscular junction
Gohel, C., Grigoriev, V. B., Escaig-Haye, F., Lasmézas, C. I., Deslys, J.-P., Langeveld, J., Akaaboune, M., Hantaï, D., & Fournier, J. G. (1999) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19990115)55:2<187::aid-jnr6>3.0.co;2-t · Cited by 42
Lazović, J., Soto, H., Piccioni, D. E., Ru, J. R. L., Li, S., Mirsadraei, L., Yong, W. H., Prins, R. M., Liau, L. M., Ellingson, B. M., et al. (2012) · Neuro-Oncology · doi:10.1093/neuonc/nos258 · Cited by 42
Immunotherapy in gliomas: limitations and potential of natural killer (NK) cell therapy
Ogbomo, H., Cinatl, J. J., Mody, C. H., & Forsyth, P. A. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.03.004 · Cited by 40
Kiefer, R., Supler, M. L., Toyka, K. V., & Streit, W. J. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90475-8 · Cited by 40
Maes, W., Verschuere, T., Hoylandt, A. V., Boon, L., & Gool, S. V. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/952469 · Cited by 40
McKinney, A. J., & Holmen, S. L. (2011) · 癌症:英文版 · doi:10.5732/cjc.011.10007 · Cited by 38
Circulating progenitor cells: a comparison of patients with glioblastoma or meningioma
Alexiou, G. Α., Vartholomatos, G., Karamoutsios, A., Batistatou, A. K., Kyritsis, A. P., & Voulgaris, S. (2012) · Acta Neurologica Belgica · doi:10.1007/s13760-012-0097-y · Cited by 37
Taniguchi, Y., Ono, K., Yoshida, S., & Tanaka, R. (2000) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(00)00361-1 · Cited by 37
Reaction of microglial cells in human astrocytomas (preliminary report).
Wierzba‐Bobrowicz, T., Kuchna, I., & Matyja, E. (1994) · PubMed · Cited by 37
Nakano, Y., Kuroda, E., Kito, T., Uematsu, S., Akira, S., Yokota, A., Nishizawa, S., & Yamashita, U. (2008) · Journal of neurosurgery · doi:10.3171/jns/2008/108/2/0311 · Cited by 36
Immunological characterization of glioblastoma cells for immunotherapy.
Jung, T., Choi, Y. D., Kim, Y., Lee, J., Kim, H.-S., Kim, J.-S., Kim, S., Jung, S., & Cho, D. (2013) · PubMed · Cited by 35
Versican isoform V1 regulates proliferation and migration in high-grade gliomas
Onken, J., Moeckel, S., Leukel, P., Leidgens, V., Baumann, F., Bogdahn, U., Vollmann‐Zwerenz, A., & Hau, P. (2014) · Journal of Neuro-Oncology · doi:10.1007/s11060-014-1545-8 · Cited by 32
Guillaume, T., Sekhavat, M., Rubinstein, D. B., Hamdan, O., & Symann, M. (1993) · PubMed · Cited by 29
MICROGLIA IN GEMISTOCYTIC ASTROCYTOMAS
Geranmayeh, F., Scheithauer, B. W., Spitzer, C., Meyer, F. B., Svensson-Engwall, A.-C., & Graeber, M. B. (2007) · Neurosurgery · doi:10.1227/01.neu.0000249192.30786.67 · Cited by 26
Rani, S., Barbe, M. F., Barr, A. E., & Litvin, J. (2009) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.2009.954081 · Cited by 25
Zhang, R., Banik, N. L., & Ray, S. K. (2008) · Brain Research · doi:10.1016/j.brainres.2008.08.075 · Cited by 22
Kumar, P. S., Shiras, A., Das, G., Jagtap, J. C., Prasad, V., & Shastry, P. (2007) · Molecular Cancer · doi:10.1186/1476-4598-6-42 · Cited by 21
Glioma Development: Where Did It All Go Wrong?
Sukhdeo, K., Hambardzumyan, D., & Rich, J. N. (2011) · Cell · doi:10.1016/j.cell.2011.06.047 · Cited by 20
IFITM6 expression is increased in macrophages of tumor-bearing mice
Yang, Y. D. (2010) · Oncology Reports · doi:10.3892/or.2010.1092 · Cited by 20
Microglia in Gliomas: Friend or Foe?
Kaminska, B. (2014) · Springer eBooks · doi:10.1007/978-3-7091-1431-5_9 · Cited by 6
Self-citation
Cited by
Exosomal noncoding RNAs in Glioma: biological functions and potential clinical applications
Cheng, J., Meng, J., Zhu, L., & Peng, Y. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01189-3 · Cited by 319
T-cell Dysfunction in Glioblastoma: Applying a New Framework
Woroniecka, K. I., Rhodin, K. E., Chongsathidkiet, P., Keith, K. A., & Fecci, P. E. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-0047 · Cited by 315
Pathological and Molecular Features of Glioblastoma and Its Peritumoral Tissue
D’Alessio, A., Proietti, G., Sica, G., & Scicchitano, B. M. (2019) · Cancers · doi:10.3390/cancers11040469 · Cited by 275
Grabowski, M. M., Sankey, E. W., Ryan, K. J., Chongsathidkiet, P., Lorrey, S. J., Wilkinson, D. S., & Fecci, P. E. (2021) · Journal of Neuro-Oncology · doi:10.1007/s11060-020-03483-y · Cited by 270
Molecular Mechanisms of Treatment Resistance in Glioblastoma
Ou, A., Yung, W. K. A., & Majd, N. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010351 · Cited by 269
Metadata
- Authors
- Gieryng, A., Pszczolkowska, D., Walentynowicz, K. A., Rajan, W. D., & Kaminska, B.
- Venue
- Laboratory Investigation
- Publisher
- Elsevier BV
- Published
- 2017-05
- Volume
- 97
- Issue
- 5
- Pages
- 498-518
- ISSN
- 0023-6837 (ISSN-L)
- OpenAlex
- W2596548837
- Cited by
- 538
- References
- 235
- FWCI
- 16.06
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.